Works matching IS 25233548 AND DT 2022 AND VI 42 AND IP 1

Results: 11

Cover Image, Volume 42, Issue 1.

Published in:

Cancer Communications, 2022, v. 42, n. 1, p. ii, doi. 10.1002/cac2.12269

By:

Zhang, Xiaofei;
Mao, Tiebo;
Zhang, Bei;
Xu, Haiyan;
Cui, Jiujie;
Jiao, Feng;
Chen, Dongqin;
Wang, Yu;
Hu, Jiong;
Xia, Qing;
Li, Shumin;
Yue, Ming;
Ma, Jingyu;
Yao, Jiayu;
Wang, Yongchao;
Zhang, Xiao;
Chen, Shiqing;
Bai, Yuezong;
Wang, Yuexiang;
Zhang, Xuebin

Publication type:

Article

Front Cover: JUPITER‐02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps.

Published in:

Cancer Communications, 2022, v. 42, n. 1, p. i, doi. 10.1002/cac2.12263

By:

Tan, Laura Ling Ying;
Le, Quynh‐Thu;
Lee, Nancy Ying Ying;
Chua, Melvin Lee Kiang

Publication type:

Article

JUPITER‐02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps.

Published in:

Cancer Communications, 2022, v. 42, n. 1, p. 56, doi. 10.1002/cac2.12248

By:

Tan, Laura Ling Ying;
Le, Quynh‐Thu;
Lee, Nancy Ying Ying;
Chua, Melvin Lee Kiang

Publication type:

Article

Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1.

Published in:

Cancer Communications, 2022, v. 42, n. 1, p. 37, doi. 10.1002/cac2.12247

By:

Wu, Dan;
Yang, Yi;
Hou, Yiran;
Zhao, Zifeng;
Liang, Ning;
Yuan, Peng;
Yang, Tao;
Xing, Jinliang;
Li, Jibin

Publication type:

Article

Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open‐label, parallel controlled clinical study

Published in:

Cancer Communications, 2022, v. 42, n. 1, p. 3, doi. 10.1002/cac2.12225

By:

Zhang, Jie;
Pan, Yueyin;
Shi, Qin;
Zhang, Guojun;
Jiang, Liyan;
Dong, Xiaorong;
Gu, Kangsheng;
Wang, Huijuan;
Zhang, Xiaochun;
Yang, Nong;
Li, Yuping;
Xiong, Jianping;
Yi, Tienan;
Peng, Min;
Song, Yong;
Fan, Yun;
Cui, Jiuwei;
Chen, Gongyan;
Tan, Wei;
Zang, Aimin

Publication type:

Article

Nut and peanut butter consumption and risk of prostate cancer in the NIH‐AARP diet and health study.

Published in:

Cancer Communications, 2022, v. 42, n. 1, p. 65, doi. 10.1002/cac2.12230

By:

Ton, Mimi;
Ferrucci, Leah M.;
Weinstein, Stephanie J.;
Hashemian, Maryam;
Albanes, Demetrius;
Huang, Jiaqi

Publication type:

Article

RGS12 inhibits the progression and metastasis of multiple myeloma by driving M1 macrophage polarization and activation in the bone marrow microenvironment.

Published in:

Cancer Communications, 2022, v. 42, n. 1, p. 60, doi. 10.1002/cac2.12228

By:

Yuan, Gongsheng;
Huang, Yan;
Yang, Shu‐ting;
Ng, Andrew;
Yang, Shuying

Publication type:

Article

Anti‐PD‐L1/TGF‐βR fusion protein (SHR‐1701) overcomes disrupted lymphocyte recovery‐induced resistance to PD‐1/PD‐L1 inhibitors in lung cancer.

Published in:

Cancer Communications, 2022, v. 42, n. 1, p. 17, doi. 10.1002/cac2.12244

By:

Cheng, Bo;
Ding, Kaikai;
Chen, Pengxiang;
Ji, Jianxiong;
Luo, Tao;
Guo, Xiaofan;
Qiu, Wei;
Ma, Chunhong;
Meng, Xue;
Wang, Jian;
Yu, Jinming;
Liu, Yuan

Publication type:

Article

BAIAP2L1 enables cancer cell migration and facilitates phospho‐Cofilin asymmetry localization in the border cells.

Published in:

Cancer Communications, 2022, v. 42, n. 1, p. 75, doi. 10.1002/cac2.12239

By:

Pipatpanyanugoon, Nut;
Wareesawetsuwan, Nicha;
Prasopporn, Sunisa;
Poolex, Wannapan;
Pisitkun, Trairak;
Kaewkong, Worasak;
Sampattavanich, Somponnat;
Jirawatnotai, Siwanon

Publication type:

Article

Characterization of DNA damage response deficiency in pancreatic cancer patients from China.

Published in:

Cancer Communications, 2022, v. 42, n. 1, p. 70, doi. 10.1002/cac2.12238

By:

Zhang, Xiaofei;
Mao, Tiebo;
Zhang, Bei;
Xu, Haiyan;
Cui, Jiujie;
Jiao, Feng;
Chen, Dongqin;
Wang, Yu;
Hu, Jiong;
Xia, Qing;
Li, Shumin;
Yue, Ming;
Ma, Jingyu;
Yao, Jiayu;
Wang, Yongchao;
Zhang, Xiao;
Chen, Shiqing;
Bai, Yuezong;
Wang, Yuexiang;
Zhang, Xuebin

Publication type:

Article

Issue Information.

Published in:: Cancer Communications, 2022, v. 42, n. 1, p. 1, doi. 10.1002/cac2.12165
Publication type:: Article